Results
24,511 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 6 |  Kurtz GeorgeDirector, PRESIDENT AND CEO |  CRWDCrowdStrike Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $139K 565 sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $139K 565 sh |
| Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $192K 774 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $100K 399 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary |  LGNDLIGAND PHARMACEUTICALS INCOpen-market sale · 10b5-1 plan | SELL | $152K 490 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $162K 520 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $89K 280 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $140K 440 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $102K 320 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $64K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Vassil JonathanChief Revenue Officer |  TOSTToast, Inc.Open-market sale · 10b5-1 plan | SELL | $42K 1,268 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Merriman Dwight ADirector |  MDBMongoDB, Inc.Open-market sale · 10b5-1 plan | SELL | $68K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $249K 720 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $132K 383 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $198K 634 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $126K 403 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $242K 1,000 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $121K 480 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Coloma Jason VDirector, Chief Executive Officer |  MAZEMaze Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $10K 336 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $135K 388 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $225K 920 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $193K 560 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Nithrakashyap ArvindDirector, Chief Technology Officer |  RBRKRubrik, Inc.Open-market sale · 10b5-1 plan | SELL | $79K 658 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 6 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $205K 1,730 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 257 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $249K 2,087 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Tang StanleyDirector |  DASHDoorDash, Inc.Open-market sale · 10b5-1 plan | SELL | $91K 500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $166K 480 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $112K 320 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $186K 1,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Baszucki GregoryDirector |  RBLXRoblox CorpOpen-market sale · 10b5-1 plan | SELL | $35K 800 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 5 | de Verneuil VaninaEVP, General Counsel, Corp Sec |  VIRVir Biotechnology, Inc.Open-market sale · 10b5-1 plan | SELL | $15K 1,343 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Winitzer OriDirector |  LCIDLucid Group, Inc.Open-market sale · 10b5-1 plan | SELL | $3,090 1,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Baszucki GregoryDirector | RBLXRoblox Corp Open-market sale · 10b5-1 plan | SELL | $35K 800 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 4 | Borgeson BlakeDirector |  RXRXRECURSION PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $155K 40.0K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 3 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $47K 397 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 3 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $42K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Cowan ElviaSVP, Finance & CAO |  PCVXVaxcyte, Inc.Open-market sale · 10b5-1 plan | SELL | $36K 586 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $38K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $18K 100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Hopman MarkChief Commercial Officer |  BBNXBeta Bionics, Inc.Open-market sale · 10b5-1 plan | SELL | $6,253 370 sh | Nov 4, 2026 traded Nov 2, 2026 |